UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Progenics Pharmaceuticals, Inc.
-------------------------------
(Name of Issuer)
Common Stock, par value $.0013 per share
----------------------------------------
(Title of Class of Securities)
743187106
---------
(CUSIP Number)
December 31, 1997
-----------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[x] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
SCHEDULE 13G
CUSIP No. 743187106
- --------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paul W. Maddon, M.D., Ph.D.
- --------------------------------------------------------------------------
2 CHECK THE APPROPROPRIATE BOX IF A MEMBER OF A GROUP (a)_____
(b)_____
- --------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER 750,000
OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY None
OWNED BY
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 750,000
PERSON
WITH 8 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,125,000
- --------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES SEE INSTRUCTIONS) __
- --------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.0%
- --------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------
-2-
<PAGE>
Item 1(a) Name of Issuer:
Progenics Pharmaceuticals, Inc.
Item 1(a) Address of Issuer's Principal Executive Offices:
777 Old Saw Mill River Road
Tarrytown, New York 10591
Item 2(a) Name of Person Filing:
Paul J. Maddon, M.D., Ph.D.
Item 2(b) Address of Principal Business Office or, if none,
Residence:
777 Old Saw Mill River Road
Tarrytown, New York 10591
Item 2(c) Citizenship:
United States of America
Item 2(d) Title of Class of Securities:
Common Stock, par value $.0013 per share
Item 2(e) CUSIP Number:
743187106
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or
Rule 13d-2(b) or (c), check whether the person filing
is a:
Not applicable
Item 4. Ownership
Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount beneficially owned: 1,125,000 shares, including
375,000 shares which the reporting person has the right
to acquire within 60 days pursuant to the exercise of
stock options granted by the issuer
(b) Percent of class: 12.0%
-3-
<PAGE>
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote
750,000 shares
(ii) Shared power to vote or to direct the vote
none
(iii) Sole power to dispose or to direct the
disposition of
750,000 shares
(iv) Shared power to dispose or to direct the
disposition of
none
Item 5. Ownership of Five Percent or Less of a Class
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of
Another Person
Not applicable
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company
Not applicable
Item 8. Identification and Classification of Members of the
Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable
Item 10. Certifications
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
/s/ Paul J. Maddon
---------------------------
Dated: February 10, 1998 Paul J. Maddon, M.D., Ph.D.
-4-
